Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines
Author:
Affiliation:
1. Dermatologikum; Hamburg Germany
2. Department of Plastic and Reconstructive Surgery; Medical University Graz; Graz Austria
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jocd.12001/fullpdf
Reference17 articles.
1. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines;Sattler;Dermatol Surg,2010
2. A Phase III study of incobotulinumtoxinA in the treatment of glabellar frown lines;Imhof;J Clin Aesthet Dermatol,2011
3. Long-term results for incobotulinum toxinA in the treatment of glabellar frown lines;Rzany;Dermatol Surg,2012
4. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines;Carruthers;J Am Acad Dermatol,2002
5. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products;Dessy;Am J Clin Dermatol,2011
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sensory Symptoms Associated with Aesthetic Botulinum Toxin A Treatments;Plastic and Reconstructive Surgery - Global Open;2022-11
2. Incobotulinum toxin A: A shelf‐stable, low‐molecular‐weight formulation;Dermatological Reviews;2022-08
3. Variable anatomy of facial muscles in the light of botulinum toxin injections;Plasticheskaya khirurgiya i esteticheskaya meditsina;2022
4. Long-term Effects of Repeated Botulinum Toxin Injection in Cosmetic Therapeutics;Annals of Plastic Surgery;2021-10-05
5. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines;Journal of Drugs in Dermatology;2020-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3